๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Long-term agalsidase beta therapy is associated with improvements in pain and quality of life among patients with Fabry disease

โœ Scribed by N. Guffon; D.P. Germain; S. Waldek; M. Banikazemi; D.A. Bushinsky; J. Charrow; P. Lee; T. Loew; A.C. Vedder; W.R. Wilcox


Book ID
117321762
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
122 KB
Volume
29
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Long-term ursodeoxycholic acid therapy i
โœ Shinji Tomida; Masato Abei; Takashi Yamaguchi; Yasushi Matsuzaki; Junichi Shoda; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 80 KB ๐Ÿ‘ 1 views

Whether ursodeoxycholic acid (UDCA) therapy alters the long-term clinical course of gallstones (GS) without stone dissolution remains unknown. We aimed to clarify the relationship between long-term UDCA therapy and risks of biliary pain or acute cholecystitis in GS patients. We also aimed to identif